End of life issues

European Journal of Cancer

Volumn 44, Issue 8, 2008, Pages 1157-1162

  Sykes, Nigel ^a,b  

^a Palliative Medicine   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Double effect; End of life care; Opioids; Palliative care; Sedatives; Symptom control

Indexed keywords

ALFENTANIL; ANTIHYPERTENSIVE AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE; BUPRENORPHINE; DIURETIC AGENT; FENTANYL; GLYCOPYRRONIUM BROMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MIDAZOLAM; MORPHINE; OPIATE; ORAL ANTIDIABETIC AGENT; OXYCODONE; PHENOBARBITAL; PHENOTHIAZINE; PROPOFOL; SCOPOLAMINE BROMIDE; SUFENTANIL;

AGITATION; ARTICLE; CANCER PATIENT; DYING; DYSPNEA; ETHICS; HUMAN; INTERPERSONAL COMMUNICATION; PAIN; PATIENT CARE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RESTLESSNESS; SEDATION; SYMPTOM; TENSION;

ANALGESICS, OPIOID; CONSCIOUS SEDATION; DYSPNEA; ETHICS, MEDICAL; HUMANS; NEOPLASMS; PAIN; PSYCHOMOTOR AGITATION; QUALITY OF HEALTH CARE; RESPIRATORY SOUNDS; TERMINAL CARE; TERMINALLY ILL;

EID: 43449085186     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2008.02.035     Document Type: Article

References (42)

1. Brenner H. Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis. Lancet 360 (2002) 1131-1135
2. Office for National Statistics. Cancer Survival, England 1999-2004. .
3. Healthcare Commission, 2007. .
4. Ellershaw J., and Ward C. Care of the dying: a pathway to excellence (2003), Oxford University Press, Oxford
5. Richards M. End of life care strategy for adults - emerging themes. London: End of Life Care Strategy Advisory Board, 2007. .
6. Hinton J. Which patients with terminal cancer are admitted from home care?. Palliative Med 8 (1994) 197-210
7. National care of the dying audit - hospitals (NCDAH). Royal College of Physicians: Summary Report, 5th December 2007.
8. Glare P., Virik K., Jones M., et al. A systematic review of physicians' survival predictions in terminally ill cancer patients. Br Med J 327 (2003) 195-200
9. Maltoni M., Caraceni A., Brunelli C., Broeckaert B., Christakis N., et al. Prognostic factors in advanced cancer patients: evidence-based clinical recommendations - a study for the Steering Committee of the European Association for Palliative Care. J Clin Oncol 23 (2005) 6240-6248
10. Wildiers H., and Menten J. Death rattle: prevalence, prevention and treatment. J Pain Symptom Manage 23 (2002) 310-317
11. Ellershaw J.E., Sutcliffe J.M., and Saunders C.M. Dehydration and the dying patient. J Pain Symptom Manage 10 (1995) 192-197
12. Morita T., Ichiki T., Tsunoda J., Inoue S., and Chihara S. A prospective study on the dying process in terminally ill cancer patients. Am J Hospice Pall Care 15 (1998) 217-222
13. Fainsinger R., Waller A., Bercovici M., et al. A multicentre international study of sedation for uncontrolled symptoms in terminally ill patients. Palliative Med 14 (2000) 257-265
14. Gregory A., Todd J., and Wanklyn S. Out-of-hours prescribing: a survey of current practice in the UK. Palliative Med 21 (2007) 575-580
15. Cantwell P., Turco S., Brenneis C., Hanson J., Neumann C.M., and Bruera E. Predictors of home death in palliative care cancer patients. J Pall Care 16 1 (2000) 23-28
16. Fainsinger R., Miller M.J., Bruera E., Hanson J., and Meceachem T. Symptom control during the last week of life on a palliative care unit. J Pall Care 7 (1991) 5-11
17. Ellershaw J., Smith C., Overill S., Walker S.E., and Aldridge J. Care of the dying: setting standards for symptom control in the last 48 hours of life. J Pain Symptom Manage 21 (2001) 12-17
18. Mercadante S., Casuccio A., and Fulfaro F. The course of symptom frequency and intensity in advanced cancer patients followed at home. J Pain Symptom Manage 20 (2000) 104-112
19. Dean M. Opioids in renal failure and dialysis patients. J Pain Symptom Manage 28 (2004) 497-504
20. Booth S., Kelly M.J., Cox N.P., Adams L., and Guz A. Does oxygen help dyspnea in patients with cancer. Am J Respir Crit Care Med 153 (1996) 1515-1518
21. Jennings A.L., Davies A.N., Higgins J.P., and Broadley K. Opioids for the palliation of breathlessness in terminal illness. Cochrane Database Syst Rev 4 (2001) CD002066
22. Porter M.R., Musselman D.L., McDaniel J.S., and Nemeroff C.B. From sadness to major depression: assessment and management in patients with cancer. In: Portenoy R.K., and Bruera E. (Eds). Topics in palliative care vol. 3 (1998), Oxford University Press, New York (NY) 193
23. Breitbart W., Chochinov H.M., and Passik S. Psychiatric aspects of palliative care. In: Doyle D., Hanks G.W.C., and MacDonald N. (Eds). Oxford textbook of palliative medicine. 2nd ed. (1998), Oxford Medical Publications, Oxford 937
24. Stirling L.C., Kurowska A., and Tookman A. The use of phenobarbitone in the management of agitation and seizures at the end of life. J Pain Symptom Manage 17 (1999) 363-368
25. Lundstrom S., Zachrisson U., and Furst C.J. When nothing helps: propofol as sedative and antiemetic in palliative cancer care. J Pain Symptom Manage 30 (2005) 570-577
26. Fohr S.A. The double effect of pain medication: separating myth from reality. J Pall Med 1 (1998) 315-328
27. Williams G. The principle of double effect and terminal sedation. Med Law Rev 9 (2001) 41-53
28. Quill T.E. The ambiguity of clinical intentions. N Engl J Med 329 (1993) 1039-1040
29. Sykes N.P., and Thorns A. The use of opioids and sedatives at the end of life. Lancet Oncol 4 (2003) 312-318
30. Portenoy R., Sibirceva U., Smout R., et al. Opioid use and survival at the end of life: a survey of a hospice population. J Pain Symptom Manag 32 (2006) 532-540
31. Thorns A., and Sykes N. Opioid use in the last week of life and implications for end-of-life decision-making. Lancet 356 (2000) 398-399
32. Morita T., Tei Y., and Inoue S. Agitated terminal delirium and association with partial opioid substitution and hydration. J Palliative Med 6 (2003) 557-563
33. Quill T.E. Legal regulation of physician-assisted death - the latest report cards. N Engl J Med 356 (2007) 1911-1913
34. Fainsinger R.L. Use of sedation by a hospital palliative care support team. J Pall Care 14 1 (1998) 51-54
35. Turner K., Chye R., Aggarwal G., Philip J., Skeels A., and Lickiss J.N. Dignity in dying: a preliminary study of patients in the last three days of life. J Pall Care 12 2 (1996) 7-13
36. Porta Sales J.P. Sedation and terminal care. Eur J Pall Care 8 (2001) 97-100
37. Sykes N.P., and Thorns A. The use of opioids and sedatives at the end of life. Lancet Oncol 4 (2003) 312-318
38. De Graeff A., and Dean M. Palliative sedation therapy in the last weeks of life: a literature review and recommendations for standards. J Pall Med 10 (2007) 67-85
39. Morita T., Akechi T., Sugawara Y., Chihara S., and Uchitmi Y. Practices and attitudes of Japanese oncologists and palliative care physicians concerning terminal sedation: A nationwide survey. J Clin Oncol 20 (2002) 758-764
40. Morita T., Hyode I., Yoshima T., et al. Artificial hydration therapy, laboratory findings and fluid balance in terminally ill patients with abdominal malignancies. J Pain Symptom Manage 31 (2006) 130-139
41. Craig G.M. On withholding nutrition and hydration in the terminally ill: has palliative medicine gone too far?. J Med Ethics 20 (1994) 139-143
42. Dunlop R.J., Ellershaw J.E., Baines M.J., and Sykes N.P. On withholding nutrition and hydration in the terminally ill: has palliative medicine gone too far? A reply. J Med Ethics 21 (1995) 141-143